AstraZeneca Says No Evidence Vaccine Increases Blood-Clot Risk
AstraZeneca Plc said a “careful” review of all available data of the more than 17 million people in the European Union and the U.K. it has vaccinated against so far against Covid-19 shows no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia.
The company says it is continually monitoring the safety of its vaccine.
To view the source of this information click here
©2021 Bloomberg L.P.